S&P 500   4,455.48
DOW   34,798.00
QQQ   373.33
S&P 500   4,455.48
DOW   34,798.00
QQQ   373.33
S&P 500   4,455.48
DOW   34,798.00
QQQ   373.33
S&P 500   4,455.48
DOW   34,798.00
QQQ   373.33
LON:DNL

Diurnal Group Share Forecast, Price & News

GBX 55.10
-0.90 (-1.61 %)
(As of 09/24/2021 12:00 AM ET)
Add
Compare
Today's Range
55.10
55.10
50-Day Range
52.50
63
52-Week Range
47
97.98
Volume18,763 shs
Average Volume302,402 shs
Market Capitalization£93.07 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
30 days | 90 days | 365 days | Advanced Chart
Receive DNL News and Ratings via Email

Sign-up to receive the latest news and ratings for Diurnal Group and its competitors with MarketBeat's FREE daily newsletter.


Diurnal Group logo

About Diurnal Group

Diurnal Group plc operates as a specialty pharma company worldwide. The company develops hormone therapeutics for the treatment of chronic endocrine conditions, including congenital adrenal hyperplasia, adrenal insufficiency, hypogonadism, and hypothyroidism. The company offers Alkindi, a replacement therapy for paediatric adrenal insufficiency in Europe. It also develops Chronocort, which completed Phase III clinical trials targeting congenital adrenal hyperplasia and adrenal insufficiency. The company's early stage pipeline products comprise Native Oral Testosterone, a replacement treatment for patients suffering from hypogonadism; siRNA, a short interfering RNA oligonucleotide therapy for patients suffering from adrenocorticotropin-dependent Cushing's syndrome; and T3 modified, a modified-release preparation of T3 (levothyroxine) hormone for patients suffering from hypothyroidism. Diurnal Group plc was incorporated in 2015 and is headquartered in Cardiff, the United Kingdom.

Headlines

Diurnal Group PLC : Commercial launch of Efmody in the UK
Diurnal Group PLC : Commercial launch of Efmody in the UK
September 16, 2021 |  markets.businessinsider.com
Diurnal Group plc (LON:DNL) Insider Acquires £10,468.44 in Stock
Diurnal Group plc (LON:DNL) Insider Acquires £10,468.44 in Stock
September 15, 2021 |  americanbankingnews.com
Diurnal Group (LON:DNL) Stock Price Down 0.7%
Diurnal Group (LON:DNL) Stock Price Down 0.7%
September 11, 2021 |  americanbankingnews.com
Diurnal Group PLC : Business and Trading Update
Diurnal Group PLC : Business and Trading Update
August 8, 2021 |  markets.businessinsider.com
Diurnal Group PLC : Director Dealings
Diurnal Group PLC : Director Dealings
July 15, 2021 |  markets.businessinsider.com
Diurnal Group PLC : Director Dealings and Issue of Equity
Diurnal Group PLC : Director Dealings and Issue of Equity
July 10, 2021 |  markets.businessinsider.com
See More Headlines

Industry, Sector and Symbol

Sales & Book Value

Profitability

Debt

Price-To-Earnings

Miscellaneous


MarketRank

Overall MarketRank

1.29 out of 5 stars

Analyst Opinion: 0.0Community Rank: 4.8Dividend Strength: 0.0Insider Behavior: 1.7Valuation: 0.0 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles











Diurnal Group (LON:DNL) Frequently Asked Questions

What stocks does MarketBeat like better than Diurnal Group?

Wall Street analysts have given Diurnal Group a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Diurnal Group wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

How were Diurnal Group's earnings last quarter?

Diurnal Group plc (LON:DNL) posted its quarterly earnings results on Tuesday, September, 15th. The company reported ($4.30) earnings per share (EPS) for the quarter, topping the Zacks' consensus estimate of ($6.70) by $2.40.
View Diurnal Group's earnings history
.

How has Diurnal Group's stock been impacted by Coronavirus (COVID-19)?

Diurnal Group's stock was trading at GBX 34 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, DNL stock has increased by 62.1% and is now trading at GBX 55.10.
View which stocks have been most impacted by COVID-19
.

Who are Diurnal Group's key executives?

Diurnal Group's management team includes the following people:
  • Dr. Martin Whitaker B.Sc., BSc, Ph.D., CEO & Exec. Director
  • Mr. Richard Edward Bungay A.C.A., B.Sc., BSc, ACA, CFO, Company Sec. & Director (Age 52, Pay $364k)
  • Prof. Richard Ross, Chief Scientific Officer & Exec. Director
  • Mr. Daniel Margetson, Director of Chemistry, Manufacturing & Controls

What other stocks do shareholders of Diurnal Group own?

What is Diurnal Group's stock symbol?

Diurnal Group trades on the London Stock Exchange (LON) under the ticker symbol "DNL."

How do I buy shares of Diurnal Group?

Shares of DNL and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

What is Diurnal Group's stock price today?

One share of DNL stock can currently be purchased for approximately GBX 55.10.

How much money does Diurnal Group make?

Diurnal Group has a market capitalization of £93.07 million and generates £4.37 million in revenue each year.

How many employees does Diurnal Group have?

Diurnal Group employs 29 workers across the globe.

What is Diurnal Group's official website?

The official website for Diurnal Group is www.diurnal.co.uk.

Where are Diurnal Group's headquarters?

Diurnal Group is headquartered at Heath Park, CARDIFF, CF14 4UJ, United Kingdom.

How can I contact Diurnal Group?

Diurnal Group's mailing address is Heath Park, CARDIFF, CF14 4UJ, United Kingdom. The company can be reached via phone at +44-29-20682069.


This page was last updated on 9/25/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.